Literature DB >> 15608465

Prenatal diagnosis and management of mainstem bronchial atresia.

Sundeep G Keswani1, Timothy M Crombleholme, Bruce R Pawel, Mark P Johnson, Alan W Flake, Holly L Hedrick, Lori J Howell, R Douglas Wilson, George H Davis, N Scott Adzick.   

Abstract

The prenatal diagnosis, natural history and management of mainstem bronchial atresia have not been described previously. We report two cases of prenatally diagnosed proximal bronchial atresia. The first patient presented at 18 weeks with sonographic and MRI findings consistent with bronchial atresia with fetal hydrops. The mother developed the mirror syndrome and labor was induced. A non-viable fetus was delivered at 25 weeks. The second patient presented at 16 weeks gestation with evidence of an intrathoracic mass that was subsequently prenatally diagnosed as a right mainstem bronchial atresia. The right lung increased rapidly in size and was associated with the onset of fetal hydrops. At 24 weeks, fetal pneumonectomy was performed but the fetus expired intraoperatively due to cardiovascular collapse. Post-mortem findings in both cases confirmed the presence of an atretic mainstem bronchus with massive enlargement of the lung. Bronchial atresia involving the mainstem bronchus is associated with a poor prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 15608465     DOI: 10.1159/000081374

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  3 in total

Review 1.  Imaging findings of bronchial atresia in fetuses, neonates and infants.

Authors:  Leonor Alamo; Yvan Vial; Carole Gengler; Reto Meuli
Journal:  Pediatr Radiol       Date:  2015-12-08

Review 2.  Congenital cystic lung disease: contemporary antenatal and postnatal management.

Authors:  Richard G Azizkhan; Timothy M Crombleholme
Journal:  Pediatr Surg Int       Date:  2008-04-05       Impact factor: 1.827

3.  Bronchial atresia in a neonate with congenital cytomegalovirus infection.

Authors:  Abdullah A Yousef
Journal:  Ann Thorac Med       Date:  2013-10       Impact factor: 2.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.